PLETAL Side Effects

7024763-4 | Pancreatitis Acute
on Sep 15, 2010 Male patient from SPAIN , 86 years of age, was diagnosed with intermittent claudication, dyslipidaemia and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Pletal dosage: 100 Mg, Bid. During the same period patient was treated with SIMVASTATIN (20 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), ADIRO (ACETYSALICYLIC ACID) (View Adiro (acetysalicylic Acid) Review and Adiro (acetysalicylic Acid) Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

7021271-1 | Intra-abdominal Haemorrhage
Patient was taking Pletal (View Usage). Patient had the following side effects: intra-abdominal haemorrhage on Sep 15, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, was diagnosed with cerebral infarction and. Pletal dosage: 100 Mg Bid, Oral. During the same period patient was treated with IRBETAN (IRBESARTAN) (View Irbetan (irbesartan) Review and Irbetan (irbesartan) Label ), T PA (T PA) (View T-pa (t-pa) Review and T-pa (t-pa) Label ).

7020417-9 | Gastric Ulcer Haemorrhage, Metastases To Liver, Small Cell Carcinoma
Adverse event was reported on Sep 14, 2010 by a Male patient taking Pletal (View Usage) (Dosage: 50 Mg, Bid Oral) was diagnosed with arteriosclerosis obliterans and. Location: JAPAN , 61 years of age, After Pletal was administered, patient had the following side effects: gastric ulcer haemorrhage, metastases to liver, small cell carcinoma. During the same period patient was treated with CRESTOR (ROSUVASTATIN) TABLET (View Crestor (rosuvastatin) Tablet Review and Crestor (rosuvastatin) Tablet Label ), CIBENOL (CIBENZOLINE SUCCINATE) (View Cibenol (cibenzoline Succinate) Review and Cibenol (cibenzoline Succinate) Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ), LENDORMIN (BROTIZOLAM) TABLET (View Lendormin (brotizolam) Tablet Review and Lendormin (brotizolam) Tablet Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), GASMOTIN (MOSAPRIDE CITRATE) (View Gasmotin (mosapride Citrate) Review and Gasmotin (mosapride Citrate) Label ), NAUZELIN (DOMPERIDONE) (View Nauzelin (domperidone) Review and Nauzelin (domperidone) Label ). Patient was hospitalized.

7018441-5 | Angina Unstable, Chest Pain, Disseminated Intravascular Coagulation, Flank Pain, Haematocrit Decreased, Metabolic Acidosis, Multi-organ Failure, Renal Haemorrhage, Thrombosis In Device
on Sep 08, 2010 Male patient from KOREA, REPUBLIC OF , 54 years of age, was diagnosed with thrombosis and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: angina unstable, chest pain (What is chest pain?), disseminated intravascular coagulation, flank pain, haematocrit decreased, metabolic acidosis, multi-organ failure, renal haemorrhage, thrombosis in device. Pletal dosage: 100 Mg, Bid, Oral. During the same period patient was treated with ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (75 Mg, Qd) (View Clopidogrel Review and Clopidogrel Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).


6994670-1 | Cardiac Failure
on Aug 31, 2010 Male patient from JAPAN , 81 years of age, was treated with Pletal (View Usage). Patient had the following side effects: cardiac failure. Pletal dosage: Oral. During the same period patient was treated with DONEPEZIL HYDROCHLORIDE (View Donepezil Hydrochloride Review and Donepezil Hydrochloride Label ).

6992646-1 | Atrial Flutter, Feeling Abnormal, Loss Of Consciousness, Sick Sinus Syndrome
Patient was taking Pletal (View Usage). After Pletal was administered, patient had the following side effects: atrial flutter, feeling abnormal, loss of consciousness, sick sinus syndrome on Sep 02, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 143.3 lb, was diagnosed with arteriosclerosis obliterans and. Pletal dosage: 50 Mg, Bid Oral; 100 Mg, Bid; Oral. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), SODIUM POLYSTYRENE SULFONATE (View Sodium Polystyrene Sulfonate Review and Sodium Polystyrene Sulfonate Label ), MERISLON (BETAHISTINE HYDROCHLORIDE) TABLET (View Merislon (betahistine Hydrochloride) Tablet Review and Merislon (betahistine Hydrochloride) Tablet Label ). Patient was hospitalized.

6992572-8 | Atrial Fibrillation, Cardiac Failure, Tachycardia
Adverse event was reported on Aug 31, 2010 by a Male patient taking Pletal (View Usage) (Dosage: Oral) . Location: JAPAN , 77 years of age, Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure, tachycardia. During the same period patient was treated with DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ).

6992552-2 | Gastric Haemorrhage, Pneumonia, Respiratory Disorder, Tumour Haemorrhage
on Sep 01, 2010 Male patient from JAPAN , 82 years of age, was treated with Pletal (View Usage). Patient had the following side effects: gastric haemorrhage, pneumonia (What is pneumonia?), respiratory disorder, tumour haemorrhage. Pletal dosage: Oral. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), PARIET (RABEPRAZOLE SODIUM) TABLET (View Pariet (rabeprazole Sodium) Tablet Review and Pariet (rabeprazole Sodium) Tablet Label ).

6987374-2 | Decreased Appetite, Gait Disturbance, Pyrexia, Respiratory Arrest
on Sep 01, 2010 Female patient from JAPAN , 87 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: decreased appetite, gait disturbance, pyrexia, respiratory arrest. Pletal dosage: 50 Mg, Qd. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CONIEL (BENIDIPINE HYDROCHLORIDE) (View Coniel (benidipine Hydrochloride) Review and Coniel (benidipine Hydrochloride) Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), TENORMIN (View Tenormin Review and Tenormin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ALFAROL (ALFACALCIDOL) (View Alfarol (alfacalcidol) Review and Alfarol (alfacalcidol) Label ), BONALON (ALENDRONATE SODIUM HYDRATE) (View Bonalon (alendronate Sodium Hydrate) Review and Bonalon (alendronate Sodium Hydrate) Label ), MADOROS (MALTOSE) (View Madoros (maltose) Review and Madoros (maltose) Label ).

6985212-5 | Bleeding Time Prolonged, Complication Of Device Insertion, Fistula, Haematemesis, Haemoglobin Decreased, Operative Haemorrhage
Patient was taking Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: bleeding time prolonged, complication of device insertion, fistula (What is fistula?), haematemesis, haemoglobin decreased, operative haemorrhage on Aug 27, 2010 from JAPAN Additional patient health information: Female patient , 83 years of age, was diagnosed with cerebral infarction and. Pletal dosage: 100 Mg, Bid,. During the same period patient was treated with WARFARIN SODIUM (1.5 Mg, Qd,) (View Warfarin Sodium Review and Warfarin Sodium Label ), OPALMON(LIMAPROST) TABLET (5 Ug, Tid,) (View Opalmon(limaprost) Tablet Review and Opalmon(limaprost) Tablet Label ), DIGOSIN (DIGOXIN), 0.1 % (View Digosin (digoxin), 0.1 % Review and Digosin (digoxin), 0.1 % Label ), TANATRIL (IMIDAPRIL HYDROCHLORIDE) TABLET (View Tanatril (imidapril Hydrochloride) Tablet Review and Tanatril (imidapril Hydrochloride) Tablet Label ). Patient was hospitalized.

6982072-3 | Cardiac Failure, Condition Aggravated, Myocardial Infarction, Pulmonary Congestion, Rales
Adverse event was reported on Apr 08, 2010 by a Male patient taking Pletal (View Usage) (Dosage: 100 Mg, Bid Oral) was diagnosed with arteriosclerosis obliterans and. Location: JAPAN , 80 years of age, Patient had the following side effects: cardiac failure, condition aggravated, myocardial infarction, pulmonary congestion, rales. During the same period patient was treated with PRAVARON (PRAVASTATIN SODIUM) TABLET (View Pravaron (pravastatin Sodium) Tablet Review and Pravaron (pravastatin Sodium) Tablet Label ), BAYMYCARD (NISOLDIPINE) TABLET (View Baymycard (nisoldipine) Tablet Review and Baymycard (nisoldipine) Tablet Label ), ACECOL (TEMOCAPRIL HYDROCHLORIDE) TABLET (View Acecol (temocapril Hydrochloride) Tablet Review and Acecol (temocapril Hydrochloride) Tablet Label ), NICORANDIS (NICORANDIL) TABLET (View Nicorandis (nicorandil) Tablet Review and Nicorandis (nicorandil) Tablet Label ). Patient was hospitalized.

6980280-9 | Condition Aggravated, Dizziness Postural, Hypertension, Subarachnoid Haemorrhage
on Aug 25, 2010 Female patient from JAPAN , 73 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: condition aggravated, dizziness postural, hypertension, subarachnoid haemorrhage. Pletal dosage: 100 Mg, Bid, Orl. During the same period patient was treated with BUFFERIN (330 Mg, Qd, Oral) (View Bufferin Review and Bufferin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ATELEC (CILNIDIPINE) TABLET (View Atelec (cilnidipine) Tablet Review and Atelec (cilnidipine) Tablet Label ), CELOOP (TEPRENONE) CAPSULE (View Celoop (teprenone) Capsule Review and Celoop (teprenone) Capsule Label ), U PAN (LORAZEPAM) TABLET (View U-pan (lorazepam) Tablet Review and U-pan (lorazepam) Tablet Label ), MINZAIN (TRIAZOLAM) TABLET (View Minzain (triazolam) Tablet Review and Minzain (triazolam) Tablet Label ), JZOLOFT (SERTRALINE HYDROCHLORIDE) TABLET (View Jzoloft (sertraline Hydrochloride) Tablet Review and Jzoloft (sertraline Hydrochloride) Tablet Label ). Patient was hospitalized.

6970716-1 | Peripheral Ischaemia
on Aug 23, 2010 Female patient from JAPAN , 93 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: peripheral ischaemia. Pletal dosage: 50 Mg, Bid, Oral. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ARICEPT (View Aricept Review and Aricept Label ).

6970684-2 | Haemorrhage, Hypochromic Anaemia, Iron Deficiency, Muscle Spasms
Patient was taking Pletal (View Usage). Patient had the following side effects: haemorrhage, hypochromic anaemia, iron deficiency, muscle spasms on Aug 19, 2010 from GERMANY Additional patient health information: Male patient , 70 years of age, weighting 191.8 lb, was diagnosed with arterial occlusive disease and. Pletal dosage: 100 Mg, Oral. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ). Patient was hospitalized.

6967272-0 | Anaemia, Reflux Oesophagitis, Tachycardia
Adverse event was reported on Aug 20, 2010 by a Male patient taking Pletal (View Usage) (Dosage: 100 Mg, Bid, Oral) was diagnosed with cerebral infarction and. Location: JAPAN , 49 years of age, weighting 138.9 lb, After Pletal was administered, patient had the following side effects: anaemia, reflux oesophagitis, tachycardia. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6967269-0 | Haemorrhage, Hypochromic Anaemia, Iron Deficiency, Muscle Spasms
on Aug 19, 2010 Male patient from GERMANY , 70 years of age, weighting 191.8 lb, was diagnosed with arterial occlusive disease and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage, hypochromic anaemia, iron deficiency, muscle spasms. Pletal dosage: 100 Mg, Bid, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6959635-4 | Gastric Ulcer Haemorrhage, Haematemesis
on Aug 17, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). Patient had the following side effects: gastric ulcer haemorrhage, haematemesis. Pletal dosage: 50 Mg, Bid Oral. During the same period patient was treated with CRESTOR (ROSUVASTATIN) TABLET (View Crestor (rosuvastatin) Tablet Review and Crestor (rosuvastatin) Tablet Label ), CIBENOL (CIBENZOLINE SUCCINATE) (View Cibenol (cibenzoline Succinate) Review and Cibenol (cibenzoline Succinate) Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ), LENDORMIN (BROTIZOLAM) TABLET (View Lendormin (brotizolam) Tablet Review and Lendormin (brotizolam) Tablet Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), GASMOTIN (MOSAPRIDE CITRATE) (View Gasmotin (mosapride Citrate) Review and Gasmotin (mosapride Citrate) Label ), NAUZELIN (DOMPERIDONE) (View Nauzelin (domperidone) Review and Nauzelin (domperidone) Label ). Patient was hospitalized.

6956828-7 | Pancreatitis Acute
Patient was taking Pletal (View Usage). After Pletal was administered, patient had the following side effects: pancreatitis acute on Aug 16, 2010 from SPAIN Additional patient health information: Male patient , 86 years of age, was diagnosed with intermittent claudication, dyslipidaemia and. Pletal dosage: 100 Mg, Bid, Oral. During the same period patient was treated with SIMVASTATIN (20 Mg, Qd, Oral) (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6942102-1 | Agranulocytosis, Leukaemia, Thrombocytopenia
Adverse event was reported on Aug 09, 2010 by a Female patient taking Pletal (View Usage) (Dosage: 50 Mg, Bid Oral) was diagnosed with arterial occlusive disease and. Location: JAPAN , 77 years of age, weighting 78.26 lb, Patient experienced the following unwanted or unexpected effects: agranulocytosis, leukaemia, thrombocytopenia. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PARIET (SODIUM RABEPRAZOLE) TABLET (View Pariet (sodium Rabeprazole) Tablet Review and Pariet (sodium Rabeprazole) Tablet Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ), ADALATE (NIFEDIPINE) TABLET (View Adalate (nifedipine) Tablet Review and Adalate (nifedipine) Tablet Label ), DIOVAN (View Diovan Review and Diovan Label ), METHYCOBAL (MECOBALAMIN) (View Methycobal (mecobalamin) Review and Methycobal (mecobalamin) Label ), KINEDAK (EPALRESTAT) TABLET (View Kinedak (epalrestat) Tablet Review and Kinedak (epalrestat) Tablet Label ).

6942100-8 | Acute Myeloid Leukaemia, Eosinophil Count Increased, Granulocyte Count Decreased, Myelodysplastic Syndrome, Platelet Count Decreased
on Aug 19, 2010 Female patient from JAPAN , 77 years of age, weighting 78.26 lb, was diagnosed with arterial occlusive disease, neuropathy peripheral and was treated with Pletal (View Usage). Patient had the following side effects: acute myeloid leukaemia, eosinophil count increased, granulocyte count decreased, myelodysplastic syndrome, platelet count decreased. Pletal dosage: 50 Mg, Bid Oral. During the same period patient was treated with KINEDAK (EPALRESTAT) TABLET (50 Mg, Tid Oral) (View Kinedak (epalrestat) Tablet Review and Kinedak (epalrestat) Tablet Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), PARIET (SODIUM RABEPRAZOLE) (View Pariet (sodium Rabeprazole) Review and Pariet (sodium Rabeprazole) Label ), DIOVAN (View Diovan Review and Diovan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ), METHYCOBAL (MECOBALAMIN) (View Methycobal (mecobalamin) Review and Methycobal (mecobalamin) Label ), NOVORAPID (INSULIN ASPART (GENETICAL RECOMBINATION)) (View Novorapid (insulin Aspart (genetical Recombination)) Review and Novorapid (insulin Aspart (genetical Recombination)) Label ).

6939602-7 | Cardiac Failure
on Aug 10, 2010 Male patient from GERMANY , weighting 176.4 lb, was diagnosed with peripheral arterial occlusive disease and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: cardiac failure. Pletal dosage: 100 Mg, Daily Dose Oral.

6939421-1 | Cerebellar Haemorrhage
Patient was taking Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: cerebellar haemorrhage on Aug 04, 2010 from JAPAN Additional patient health information: Male patient , 76 years of age, was diagnosed with arteriosclerosis obliterans and. Pletal dosage: 200mg, Daily Dose Oral. During the same period patient was treated with PLAVIX (25 Mg, Dailydose Oral) (View Plavix Review and Plavix Label ), ADALAT (View Adalat Review and Adalat Label ), DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

6939418-1 | Gait Disturbance, Infection
Adverse event was reported on Aug 06, 2010 by a Female patient taking Pletal (View Usage) (Dosage: 50 Mg, Qd Oral) was diagnosed with arteriosclerosis obliterans and. Location: JAPAN , 87 years of age, Patient had the following side effects: gait disturbance, infection (What is infection?). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CONIEL (BENIDIPINE HYDROCHLORIDE) (View Coniel (benidipine Hydrochloride) Review and Coniel (benidipine Hydrochloride) Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), TENORMIN (View Tenormin Review and Tenormin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ALFAROL (ALFACALCIDOL) (View Alfarol (alfacalcidol) Review and Alfarol (alfacalcidol) Label ), BONALON (ALENDRONATE SODIUM HYDRATE) (View Bonalon (alendronate Sodium Hydrate) Review and Bonalon (alendronate Sodium Hydrate) Label ).

6939417-X | Peripheral Ischaemia
on Aug 04, 2010 Female patient from JAPAN , 93 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: peripheral ischaemia. Pletal dosage: 50 Mg, Bid Oral. During the same period patient was treated with AGENTS FOR HYPERLIPIDEMIAS (View Agents For Hyperlipidemias Review and Agents For Hyperlipidemias Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6939416-8 | Bone Marrow Failure, Carotid Artery Stent Insertion
on Aug 04, 2010 Female patient from JAPAN , 82 years of age, was diagnosed with cerebral infarction and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, carotid artery stent insertion. Pletal dosage: 100 Mg, Bid Oral. During the same period patient was treated with PLAVIX (75 Mg, Qd Oral) (View Plavix Review and Plavix Label ), BAYASPIRIN (ACETYLSALCYLIC ACID) (View Bayaspirin (acetylsalcylic Acid) Review and Bayaspirin (acetylsalcylic Acid) Label ), CLARITH (CLARITHROMYCOM) (View Clarith (clarithromycom) Review and Clarith (clarithromycom) Label ), RADICUT (EDARAVONE) (View Radicut (edaravone) Review and Radicut (edaravone) Label ), NOVATAN HI (ARGATROBAN) (View Novatan Hi (argatroban) Review and Novatan Hi (argatroban) Label ), HEPARIN AND PREPARATIONS (HEPARIN AND PREPARATIONS) (View Heparin And Preparations (heparin And Preparations) Review and Heparin And Preparations (heparin And Preparations) Label ), MUCOSTA (REBAMIPIDE) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ), PANTOSIN (PANTETHINE) (View Pantosin (pantethine) Review and Pantosin (pantethine) Label ).

6933576-0 | Blood Pressure Decreased, Overdose
Patient was taking Pletal (View Usage). Patient had the following side effects: blood pressure decreased, overdose on Aug 03, 2010 from JAPAN Additional patient health information: Female patient , 95 years of age, was diagnosed with cerebral infarction, hypertension and. Pletal dosage: 100 Mg, Bid Oral. During the same period patient was treated with AVAPRO (50 Mg, Qd Oral) (View Avapro Review and Avapro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), ARICEPT (View Aricept Review and Aricept Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6933549-8 | Myocardial Infarction
Adverse event was reported on Aug 03, 2010 by a Female patient taking Pletal (View Usage) (Dosage: 100 Mg, Bid Oral) was diagnosed with arteriosclerosis obliterans, dyslipidaemia and. Location: JAPAN , 83 years of age, After Pletal was administered, patient had the following side effects: myocardial infarction. During the same period patient was treated with EPADEL (ETHYL ICOSAPENTATE) CAPSULE (900 Mg, Bid Oral) (View Epadel (ethyl Icosapentate) Capsule Review and Epadel (ethyl Icosapentate) Capsule Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), NOVOLIN N (INSULIN HUMAN(GENETICAL RECOMBINATION)) (View Novolin N (insulin Human(genetical Recombination)) Review and Novolin N (insulin Human(genetical Recombination)) Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ). Patient was hospitalized.

6933537-1 | Haemorrhagic Anaemia, Oesophageal Haemorrhage
on Aug 04, 2010 Male patient from JAPAN , 49 years of age, was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhagic anaemia, oesophageal haemorrhage. Pletal dosage: 100 Mg, Qd Oral. During the same period patient was treated with LENDORMIN D (BROTIZOLAM) (View Lendormin D (brotizolam) Review and Lendormin D (brotizolam) Label ), VOLTAREN (View Voltaren Review and Voltaren Label ).

6933536-X | Hypotension, Overdose
on Aug 03, 2010 Female patient from JAPAN , 90 years of age, was diagnosed with cerebral infarction, hypertension and was treated with Pletal (View Usage). Patient had the following side effects: hypotension, overdose. Pletal dosage: 100 Mg, Bid Oral. During the same period patient was treated with REZALTAS (OLMESARTAN MEDOXOMIL_AZELNIDIPINE) TABLET (Qd; Oral) (View Rezaltas (olmesartan Medoxomil_azelnidipine) Tablet Review and Rezaltas (olmesartan Medoxomil_azelnidipine) Tablet Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6926029-7 | Angina Unstable, Coronary Artery Stenosis, Pneumonia, Respiratory Disorder
Patient was taking Pletal (View Usage). After Pletal was administered, patient had the following side effects: angina unstable, coronary artery stenosis, pneumonia (What is pneumonia?), respiratory disorder on Jul 28, 2010 from JAPAN Additional patient health information: Male patient , 82 years of age, . Pletal dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

6925315-4 | Agranulocytosis, Bone Marrow Failure, Cerebral Infarction
Adverse event was reported on Jul 29, 2010 by a Female patient taking Pletal (View Usage) (Dosage: 100 Mg, Bid Oral) was diagnosed with cerebral infarction, bronchitis (What is bronchitis?) and. Location: JAPAN , 82 years of age, weighting 46.78 lb, Patient experienced the following unwanted or unexpected effects: agranulocytosis, bone marrow failure, cerebral infarction. During the same period patient was treated with ASPIRIN (300 Mg, Daily Dose Oral, 100 Mg, Qd;oral) (View Aspirin Review and Aspirin Label ), PLAVIX (75 Mg, Qd; Oral) (View Plavix Review and Plavix Label ), CLARITH (CLARITHROMYCIN) TABLET, 200 MG (200 Mg, Bid; Oral) (View Clarith (clarithromycin) Tablet, 200 Mg Review and Clarith (clarithromycin) Tablet, 200 Mg Label ), RADICUT (EDARAVONE) INJECTION (View Radicut (edaravone) Injection Review and Radicut (edaravone) Injection Label ), NOVASTATIN HI (ARGATROBAN) INJECTION (View Novastatin Hi (argatroban) Injection Review and Novastatin Hi (argatroban) Injection Label ), HEPARIN AND PREPARATION (HEPARIN AND PREPARATIONS) INJECTION (View Heparin And Preparation (heparin And Preparations) Injection Review and Heparin And Preparation (heparin And Preparations) Injection Label ).

6925314-2 | Eosinophil Count Increased, Granulocyte Count Decreased, Myelodysplastic Syndrome, Platelet Count Decreased
on Jul 29, 2010 Female patient from JAPAN , 77 years of age, weighting 78.26 lb, was diagnosed with arterial occlusive disease, neuropathy peripheral and was treated with Pletal (View Usage). Patient had the following side effects: eosinophil count increased, granulocyte count decreased, myelodysplastic syndrome, platelet count decreased. Pletal dosage: 50 Mg, Bid Oral. During the same period patient was treated with KINEDAK (EPALRESTA) TABLET (50 Mg, Tid Oral) (View Kinedak (epalresta) Tablet Review and Kinedak (epalresta) Tablet Label ), ADALAT CR (NIFEDIPINE) TABLET (View Adalat-cr (nifedipine) Tablet Review and Adalat-cr (nifedipine) Tablet Label ), PARIET (SODIUM RABEPRAZOLE) TABLET (View Pariet (sodium Rabeprazole) Tablet Review and Pariet (sodium Rabeprazole) Tablet Label ), DIOVAN (View Diovan Review and Diovan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ), METHYCOBAL (MECOBALAMIN) (View Methycobal (mecobalamin) Review and Methycobal (mecobalamin) Label ), NOVORAPID (INSULIN ASPART(GENETICAL RECOMBINATION)) INJECTION (View Novorapid (insulin Aspart(genetical Recombination)) Injection Review and Novorapid (insulin Aspart(genetical Recombination)) Injection Label ).

6917739-6 | Anaemia, Blood Pressure Decreased, Cardiac Failure, Overdose, Pulmonary Oedema, Respiratory Rate Increased, Respiratory Tract Infection, Rib Fracture, Ventricular Fibrillation
on Jul 27, 2010 Male patient from JAPAN , 75 years of age, weighting 119.7 lb, was diagnosed with angina pectoris and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: anaemia, blood pressure decreased, cardiac failure, overdose, pulmonary oedema, respiratory rate increased, respiratory tract infection, rib fracture, ventricular fibrillation. Pletal dosage: 100 Mg, Bid Oral; 50 Mg, Bid; Oral. During the same period patient was treated with TAKEPRON (LANSOPRAZOLE) TABLET (View Takepron (lansoprazole) Tablet Review and Takepron (lansoprazole) Tablet Label ), MUCODYNE DS (CARBOCISTEINE) SYRUP (View Mucodyne Ds (carbocisteine) Syrup Review and Mucodyne Ds (carbocisteine) Syrup Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), SIGMART (NICORANDIL) TABLET (View Sigmart (nicorandil) Tablet Review and Sigmart (nicorandil) Tablet Label ). Patient was hospitalized.

6907640-6 | Dizziness, Ear Haemorrhage, Urinary Retention, Visual Acuity Reduced
Patient was taking Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), ear haemorrhage, urinary retention, visual acuity reduced on Jun 22, 2010 from SPAIN Additional patient health information: Male patient , 54 years of age, was diagnosed with venous insufficiency, neuropathy peripheral and. Pletal dosage: 100 Mg, Oral. During the same period patient was treated with CLOPIDOGREL (75 Mg, Oral) (View Clopidogrel Review and Clopidogrel Label ), HIDROXIL B12 B6 B1 (HYDROXOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMI (Oral) (View Hidroxil B12 B6 B1 (hydroxocobalamin, Pyridoxine Hydrochloride, Thiami Review and Hidroxil B12 B6 B1 (hydroxocobalamin, Pyridoxine Hydrochloride, Thiami Label ), GABAPENTIN (300 Mg, Qd, Oral) (View Gabapentin Review and Gabapentin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SUTRIL (TORASEMIDE) (View Sutril (torasemide) Review and Sutril (torasemide) Label ).

6907635-2 |
Adverse event was reported on Jul 21, 2010 by a Female patient taking Pletal (View Usage) (Dosage: 50 Mg, Qd, Oral) was diagnosed with arteriosclerosis obliterans and. Location: JAPAN , 87 years of age, . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CONIEL (BENIDIPINE HYDROCHLORIDE) (View Coniel (benidipine Hydrochloride) Review and Coniel (benidipine Hydrochloride) Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), TENORMIN (View Tenormin Review and Tenormin Label ), ITOROL (ALFACALCIDOL) (View Itorol (alfacalcidol) Review and Itorol (alfacalcidol) Label ), BONALON (ALENDRONATE SODIUM HYDRATE) (View Bonalon (alendronate Sodium Hydrate) Review and Bonalon (alendronate Sodium Hydrate) Label ).

6894468-9 | Haemorrhagic Anaemia, Oesophageal Haemorrhage
on Jul 14, 2010 Male patient from JAPAN , 49 years of age, was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: haemorrhagic anaemia, oesophageal haemorrhage. Pletal dosage: Oral.

6894461-6 | Aphasia, Brain Compression, Cerebral Hyperperfusion Syndrome, Cerebral Infarction, Headache, Hepatic Function Abnormal, Muscle Swelling, Post Procedural Haematoma
on Jul 15, 2010 Male patient from JAPAN , 35 years of age, weighting 112.4 lb, was diagnosed with moyamoya disease and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), brain compression, cerebral hyperperfusion syndrome, cerebral infarction, headache (What is headache?), hepatic function abnormal, muscle swelling, post procedural haematoma. Pletal dosage: 100 Mg, Bid Oral. During the same period patient was treated with TAKEPRON (LANSOPRAZOLE) TABLET (View Takepron (lansoprazole) Tablet Review and Takepron (lansoprazole) Tablet Label ), ALEVIATIN (PHENYTOIN) INJECTION (View Aleviatin (phenytoin) Injection Review and Aleviatin (phenytoin) Injection Label ), NORVASC (View Norvasc Review and Norvasc Label ), BLOPRESS (CANDESARTAN CILEXETIL) TABLET (View Blopress (candesartan Cilexetil) Tablet Review and Blopress (candesartan Cilexetil) Tablet Label ), RADICUT (EDARAVONE) INJECTION (View Radicut (edaravone) Injection Review and Radicut (edaravone) Injection Label ).

6894458-6 | Anaemia, Pleural Effusion, Renal Failure Acute
Patient was taking Pletal (View Usage). Patient had the following side effects: anaemia, pleural effusion, renal failure acute on Jul 15, 2010 from JAPAN Additional patient health information: Female patient , 93 years of age, was diagnosed with cardiac pacemaker insertion and. Pletal dosage: 100 Mg, Bid Oral. During the same period patient was treated with CEFDINIR (100 Mg, Tid Oral) (View Cefdinir Review and Cefdinir Label ), CEFAZOLIN SODIUM (CEFAZOLIN SODIUM) INJECTION (View Cefazolin Sodium (cefazolin Sodium) Injection Review and Cefazolin Sodium (cefazolin Sodium) Injection Label ), ARICEPT D (DONEPEZIL HYDROCHLORIDE) TABLET (View Aricept D (donepezil Hydrochloride) Tablet Review and Aricept D (donepezil Hydrochloride) Tablet Label ), LASIX (View Lasix Review and Lasix Label ), BLOPRESS (CANDESARTAN CILEXETIL) TABLET (View Blopress (candesartan Cilexetil) Tablet Review and Blopress (candesartan Cilexetil) Tablet Label ). Patient was hospitalized.

6894453-7 | Interstitial Lung Disease
Adverse event was reported on Jul 15, 2010 by a Female patient taking Pletal (View Usage) (Dosage: 50 Mg, Qd Oral) was diagnosed with cerebral infarction, back pain (What is back pain?), hyperuricaemia and. Location: JAPAN , 81 years of age, weighting 337.3 lb, After Pletal was administered, patient had the following side effects: interstitial lung disease. During the same period patient was treated with TEGRETOL (200 Mg, Qd Oral) (View Tegretol Review and Tegretol Label ), TICLOPIDINE HCL (100 Mg, Oral) (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), ALLOPURINOL (100 Mg, Oral) (View Allopurinol Review and Allopurinol Label ), SAWADOL L (ISOSORBIDE DINITRATE) TABLET (View Sawadol L (isosorbide Dinitrate) Tablet Review and Sawadol L (isosorbide Dinitrate) Tablet Label ), YODEL S (SENNA EXTRACT) TABLET (View Yodel-s (senna Extract) Tablet Review and Yodel-s (senna Extract) Tablet Label ), IRBETAN (IRBESARTAN) TABLET (View Irbetan (irbesartan) Tablet Review and Irbetan (irbesartan) Tablet Label ), PRAVATIN (PRAVASTATIN SODIUM) TABLET (View Pravatin (pravastatin Sodium) Tablet Review and Pravatin (pravastatin Sodium) Tablet Label ), ALTAT (ROXATIDINE ACETATE HYDRCHLORIDE) CAPSULE (View Altat (roxatidine Acetate Hydrchloride) Capsule Review and Altat (roxatidine Acetate Hydrchloride) Capsule Label ).

6874981-0 | Haemorrhage, Iron Deficiency, Microcytic Anaemia
on Jul 13, 2010 Male patient from GERMANY , 70 years of age, weighting 191.8 lb, was diagnosed with arterial occlusive disease and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage, iron deficiency, microcytic anaemia. Pletal dosage: 10 Mg, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ). Patient was hospitalized.

6874965-2 | Cardiac Failure, Cardiogenic Shock, Echocardiogram Abnormal
on Jul 13, 2010 Male patient from GERMANY , 64 years of age, was treated with Pletal (View Usage). Patient had the following side effects: cardiac failure, cardiogenic shock, echocardiogram abnormal. Pletal dosage: 100 Mg. During the same period patient was treated with LORZAAR (LOSARTAN POTASSIUM) (View Lorzaar (losartan Potassium) Review and Lorzaar (losartan Potassium) Label ), LORZAAR PLUS (HYDROCHLORIDE, LOSARTAN POTASSIUM) (View Lorzaar Plus (hydrochloride, Losartan Potassium) Review and Lorzaar Plus (hydrochloride, Losartan Potassium) Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6874961-5 | Nail Discolouration, Oedema Peripheral, Pleural Effusion, Weight Decreased
Patient was taking Pletal (View Usage). After Pletal was administered, patient had the following side effects: nail discolouration, oedema peripheral, pleural effusion, weight decreased on Jul 14, 2010 from JAPAN Additional patient health information: Female patient , weighting 146.4 lb, . Pletal dosage: . During the same period patient was treated with CALBLOCK (AZELNIDIPINE) (View Calblock (azelnidipine) Review and Calblock (azelnidipine) Label ), WARFARIN (WARFARIN POTASSIUM) (View Warfarin (warfarin Potassium) Review and Warfarin (warfarin Potassium) Label ), DIART (AZOSEMIDE) (View Diart (azosemide) Review and Diart (azosemide) Label ), DIOVAN (View Diovan Review and Diovan Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), TALION (BEPOTASTINE BESILATE) (View Talion (bepotastine Besilate) Review and Talion (bepotastine Besilate) Label ), ZONISAMIDE (View Zonisamide Review and Zonisamide Label ), MUCODYNE (CARBOCISTEINE) (View Mucodyne (carbocisteine) Review and Mucodyne (carbocisteine) Label ). Patient was hospitalized.

6874580-0 | Agranulocytosis, Leukaemia, Thrombocytopenia
Adverse event was reported on Jul 13, 2010 by a Female patient taking Pletal (View Usage) (Dosage: Oral) . Location: JAPAN , 77 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, leukaemia, thrombocytopenia. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PARIET (SODIUM RABEPRAZOLE) (View Pariet (sodium Rabeprazole) Review and Pariet (sodium Rabeprazole) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), DIOVAN (View Diovan Review and Diovan Label ), METHYLCOBAL (MECOBALAMIN) (View Methylcobal (mecobalamin) Review and Methylcobal (mecobalamin) Label ), KINEDAK (EPALRESTAT) (View Kinedak (epalrestat) Review and Kinedak (epalrestat) Label ).

6874579-4 | Cerebellar Haematoma, Cerebellar Haemorrhage, Pneumonia
on Jul 13, 2010 Male patient from JAPAN , 79 years of age, weighting 125.7 lb, was diagnosed with platelet aggregation inhibition and was treated with Pletal (View Usage). Patient had the following side effects: cerebellar haematoma, cerebellar haemorrhage, pneumonia (What is pneumonia?). Pletal dosage: 100 Mg, Bid, Oral. During the same period patient was treated with ASPIRIN (100 Mg, Qd, Oral) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6862465-5 | Hypotension, Overdose
on Jul 08, 2010 Female patient from JAPAN , 90 years of age, was diagnosed with cerebral infarction and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: hypotension, overdose. Pletal dosage: 100 Mg, Bid, Oral. During the same period patient was treated with REZALTAS (OLMESARTAN MEDOXOMIL AZELNIDIPINE) (Qd , Oral) (View Rezaltas (olmesartan Medoxomil Azelnidipine) Review and Rezaltas (olmesartan Medoxomil Azelnidipine) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6856862-1 | Agranulocytosis, Blood Disorder, Thrombocytopenia
Patient was taking Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, blood disorder, thrombocytopenia on Jul 06, 2010 from JAPAN Additional patient health information: Female patient , 77 years of age, . Pletal dosage: Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), DIOVAN (View Diovan Review and Diovan Label ), METHYCOBAL (MECOBALAMIN) (View Methycobal (mecobalamin) Review and Methycobal (mecobalamin) Label ), KINEDAK (EPALRESTAT) (View Kinedak (epalrestat) Review and Kinedak (epalrestat) Label ).

6843533-0 |
Adverse event was reported on Jul 01, 2010 by a Male patient taking Pletal (View Usage) (Dosage: 100 Mg, Daily Dose Oral) was diagnosed with peripheral arterial occlusive disease and. Location: GERMANY , weighting 176.4 lb, .

6837615-7 | Cardiac Failure, Tachyarrhythmia
on Jun 28, 2010 Female patient from SPAIN , 75 years of age, was diagnosed with intermittent claudication and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: cardiac failure, tachyarrhythmia. Pletal dosage: 100 Mg, Qd Oral. Patient was hospitalized.

6837611-X | Abdominal Discomfort, Diarrhoea, Lacunar Infarction, Loss Of Consciousness, Malaise, Pruritus, Tinnitus, Transient Ischaemic Attack
on Jun 29, 2010 Male patient from JAPAN , 75 years of age, weighting 150.8 lb, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, diarrhoea, lacunar infarction, loss of consciousness, malaise, pruritus, tinnitus (What is tinnitus?), transient ischaemic attack. Pletal dosage: 50 Mg, Qd Oral. During the same period patient was treated with OMEPRAL (OMEPRAZOLE) TABLET (View Omepral (omeprazole) Tablet Review and Omepral (omeprazole) Tablet Label ), AMLODIN OD (AMLODIPINE BESILATE) TABLET (View Amlodin Od (amlodipine Besilate) Tablet Review and Amlodin Od (amlodipine Besilate) Tablet Label ), GASLON N (IRSOGLADINE MALEATE) TABLET (View Gaslon N (irsogladine Maleate) Tablet Review and Gaslon N (irsogladine Maleate) Tablet Label ).

6832202-9 | Kidney Fibrosis, Renal Impairment, Renal Tubular Atrophy
Patient was taking Pletal (View Usage). Patient had the following side effects: kidney fibrosis, renal impairment, renal tubular atrophy on Jun 25, 2010 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with cerebral infarction, renal transplant and. Pletal dosage: 100 Mg, Bid, Oral. During the same period patient was treated with PROGRAF (2 Mg, Bid, Oral; 1.5 Mg, Bid, Oral) (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), MUCOSTA (REBAMIPIDE) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ), LASIX (View Lasix Review and Lasix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.